BioXcel Therapeutics, Inc. (BTAIQ)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $0.02
- As of
Kresmion compiles this page from BTAIQ's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
BioXcel Therapeutics, Inc. (BTAIQ): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-01.
See the full BTAIQ dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BTAIQ on one page. Preview it with sample data, then open it live with a free account.
Preview the BTAIQ dossierActive events for BTAIQ
No recent events on BTAIQ in the last 180 days.
FREE, NO ACCOUNT
Every event on BTAIQ, as it fires
New filings, 13F moves and cross asset events on BTAIQ land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in BTAIQ (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 09075P204 · 2026Q2 | $3M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 09075P204 · 2026Q2 | $210K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, BTAIQ
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
BTAIQ against its peers
BTAIQ's operating margin of -7860.0% ranks in the 6th percentile of 8 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-01-31 and 2026-03-31.
| Metric | BTAIQ | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 642000 USD | 1.1M USD | 45 | 9 |
| Revenue YoY | n/a | -16.7% | n/a | 6 |
| Gross margin | 74.5% | 32.1% | 81 | 7 |
| Operating margin | -7860.0% | -128.5% | 6 | 8 |
| Net margin | -10887.4% | -153.6% | 5 | 9 |
Peers (12): SXTC, STEK, CBDY, NPHC, SKYI, GCAN, CPMD, IMCC, BUDZ, PTPI, PNXP, CVSI. Left out: GREH (no annual filing), AYRWF (period gap), NTRR (period gap), CBDL (no annual filing), BNIGF (no annual filing), SFWJ (no annual filing), GRPS (period gap), KAYS (period gap), KOAN (period gap), FITY (no annual filing), NASC (period gap), CANN (period gap), PCYN (period gap). Fiscal periods ending between 2025-01-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (BTAIQ: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow BTAIQ on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to BTAIQ for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.